17 August 2017
Insights From: Emmanuel S. Antonarakis, MBBCh, Johns Hopkins Medicine; Andrew J. Armstrong, MD, MSc, Duke Cancer Center; Howard I. Scher, MD, Memorial Sloan Kettering Cancer Center share their views on the Epic Sciences AR-V7 test in development for prostate cancer.
PrintNovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Grand finale from a veritable stalwart of neuroscience
09 November 2023
Battle of pharma advocates – in search of the ideal migraine therapy
09 November 2023
NEWS Innovative method could offer cost-effective sterilisation approach
19 March 2024
In 2023, Russia has registered 540 drugs
19 March 2024
Rapid pseudomonas aeruginosa detection method developed
18 March 2024
Health Ministry has approved a drug for the treatment of Niemann–Pick disease
18 March 2024